It’s a kind of magic: the validation study has been Mobilise-D against all odds BREAKING
NEWS
Why Mobilise-D matters – now more than ever! Latest
Video
More Videos
Journal of Parkinson's Disease Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead Silvia Del Din, Cameron Kirk, Alison J Yarnall, Lynn Rochester, Jeffrey M Hausdorff Other publications LATEST
PUBLICATION
SOCIAL MEDIA New publication: A roadmap to inform development, validation and approval of digital mobility outcomes: the Mobilise-D approach BREAKING
NEWS
Why Mobilise-D matters – now more than ever! Latest
Video
More Videos
Journal of Parkinson's Disease Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead Silvia Del Din, Cameron Kirk, Alison J Yarnall, Lynn Rochester, Jeffrey M Hausdorff Other publications LATEST
PUBLICATION
SOCIAL MEDIA – I felt Mobilise-D! BREAKING
NEWS
Why Mobilise-D matters – now more than ever! Latest
Video
More Videos
Journal of Parkinson's Disease Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead Silvia Del Din, Cameron Kirk, Alison J Yarnall, Lynn Rochester, Jeffrey M Hausdorff Other publications LATEST
PUBLICATION
SOCIAL MEDIA MDS Virtual Congress 2020 BREAKING
NEWS
Why Mobilise-D matters – now more than ever! Latest
Video
More Videos
Journal of Parkinson's Disease Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead Silvia Del Din, Cameron Kirk, Alison J Yarnall, Lynn Rochester, Jeffrey M Hausdorff Other publications LATEST
PUBLICATION
SOCIAL MEDIA Mobilise-D first year achievements and first steps in year two BREAKING
NEWS
Why Mobilise-D matters – now more than ever! Latest
Video
More Videos
Journal of Parkinson's Disease Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead Silvia Del Din, Cameron Kirk, Alison J Yarnall, Lynn Rochester, Jeffrey M Hausdorff Other publications LATEST
PUBLICATION
SOCIAL MEDIA Technical validation training in Newcastle BREAKING
NEWS
Why Mobilise-D matters – now more than ever! Latest
Video
More Videos
Journal of Parkinson's Disease Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead Silvia Del Din, Cameron Kirk, Alison J Yarnall, Lynn Rochester, Jeffrey M Hausdorff Other publications LATEST
PUBLICATION
SOCIAL MEDIA

Connecting digital mobility assessment to clinical outcomes
for regulatory and clinical endorsement

What?

What?

Mobilise-D is a 5-year, IMI-funded project that will produce validated and accepted digital mobility outcomes to monitor daily life gait of people with different mobility problems, with the goal to improve follow-up and personalized care.

How?

How?

Mobilise-D will perform a technical and clinical validation of a sensor-algorithm pair in different patient groups. We maintain close dialogue with the European Medicines Agency (EMA) to facilitate the process of regulatory approval.

Who?

Who?

The Mobilise-D consortium consists of 34 partners from Europe and the USA. Over 200 professionals with technical, clinical, and regulatory expertise will work together to bring digital mobility outcomes to the clinic.                                                                  

Mobility – how well we walk – is an important marker of health; a slow walking speed is associated with greater mortality, morbidity, cognitive decline, dementia, and fall risk. As the population ages, the number of people experiencing mobility challenges is expected to rise. However, accurately assessing people’s mobility, especially in the real daily life world, is far from easy.

Mobilise-D will develop a comprehensive system to monitor and evaluate people’s gait based on digital technologies, including sensors worn on the body. The project focuses on conditions which often affect mobility, namely chronic obstructive pulmonary disease, Parkinson’s disease, multiple sclerosis, hip fracture recovery, and congestive heart failure.

The Mobilise-D results will help to improve the accurate assessment of daily life mobility in clinical trials and patient treatment, thereby contributing to improved and more personalised care.

Patient Groups

Mobilise-D will focus on five different patient groups that together represent respiratory problems (chronic obstructive pulmonary disease – COPD), neurodegenerative conditions (Parkinson’s disease – PD), neuroinflammatory problems (multiple sclerosis – MS), osteoporosis and sarcopenia (hip fracture recovery/proximal femoral fracture – PFF), and cardiac pathology (congestive heart failure – CHF).

These patient groups cover a range of walking speed, mobility challenges, and potential events that we care about, such as improving versus worsening of function, falls, hospitalisation, nursing home admission, and death. Furthermore, these patient groups will be followed at 12 different sites across Europe, ensuring a good geographical representation and covering a diverse representation of health care organisation, such as in- versus outpatient care, as well as public versus private health services.

Read More

Twitter Feed


🆕 BLOG POST 🆕

We invited one of our Mobilisers, @KirstyScott94, to share some of the daunting yet exciting experiences of being part of the Technical Validation Study in COVID-19 times. Read more below! 👇

🔗 https://t.co/Orn6Zm79tX

#mobilised #digitalhealth @IMI_JU @EFPIA

📃Our Public Newsletter 2020 is out now!📃

2020 was a turbulent and busy year for Mobilise-D in many ways, and this newsletter highlights some of the most significant news from last year. Read it here👇

🔗 https://t.co/2hCDiblFXG

#digitalhealth @IMI_JU @EFPIA https://t.co/s3KlYnUVhf
Mobilise_D photo

Latest News

It’s a kind of magic: the validation study has been Mobilise-D against all odds

All the constraints of the past year, the recurrent lockdowns, all the additional challenges we faced having to change our homes to home-offices and home-schooling, could easily have stopped us from our endeavour, but no! We managed to find our way and continue our research, our testing, and our engagement with patients. We invited one…

Upcoming Events

No event found!